Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
J Cell Biol ; 134(4): 923-34, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8769417

RESUMO

We have isolated a new female sterile mutant from Drosophila melanogaster, which arrests the embryonic development during the transition from syncytial to cellular blastoderm. Cytological analysis of the mutant embryos indicates that pseudocleavage furrows in the syncytial blastoderm are abnormal but not completely disrupted. However, cleavage furrows during cellularization are totally disorganized, and no embryos can develop beyond this stage. Consistent with this observation, the expression of this gene peaks around the cellular blastoderm and not in any later developmental stages. Based on immunofluorescence experiments, the protein product of this gene is localized in both pseudocleavage furrows at the syncytial blastoderm and in the cleavage furrows during the cellularization stage. Sequence homology analysis demonstrates a modest, but statistically significant, similarity of this protein with the carboxyl-terminal domains of dystrophin and a family of proteins collectively known as apodystrophins. It is possible that this protein may play an essential role in organizing and maintaining a specialized cytoskeletal structure, a function also suggested for dystrophin and apodystrophins.


Assuntos
Blastoderma , Proteínas de Drosophila , Drosophila melanogaster/embriologia , Regulação da Expressão Gênica no Desenvolvimento/fisiologia , Proteínas de Membrana , Proteínas/fisiologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Blastoderma/química , Clonagem Molecular , Citoesqueleto , Drosophila melanogaster/genética , Embrião não Mamífero/química , Feminino , Genes de Insetos/genética , Genes Letais/genética , Dados de Sequência Molecular , Mutação , Proteínas/análise , Proteínas/genética , RNA Mensageiro/análise , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos
2.
Gene ; 211(2): 195-203, 1998 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-9602125

RESUMO

The nucleotide sequence of the Drosophila DNA topoisomerase I gene (top1) has been determined. Structurally, top1 consists of eight exons and seven introns. The top1 coding region contains a new class of opa repeats, encoding clusters of serine residues instead of glutamine repeats usually seen in Drosophila genes of the neurogenic loci. A unique feature of top1 is the developmental switch of its transcripts: a heterogeneous population of transcripts ranging from 3.8 to 4.2kb seen maximally at 0-2h of embryogenesis and a 5.2-kb transcript maximal at 6-12h of embryonic development. The transcripts expressed in the 0-2-h embryo have been shown as maternal storage products specific to ovarian tissues. RACE analysis shows that whereas the 6-12-h transcripts have a single site for polyadenylation, there are at least 12 different sites for poly(A) addition to the 0-2-h transcripts. An additional intron specific for the maternal storage transcripts appears in some of the 0-2-h transcripts. No significant heterogeneity at the 5' end of the top1 transcripts is seen. Sequence searches have revealed a number of regulatory sequences for potential translational control in the 3' untranslated region.


Assuntos
DNA Topoisomerases Tipo I/genética , Drosophila/genética , Genes de Insetos/genética , RNA Mensageiro/genética , Animais , Sequência de Bases , Drosophila/química , Drosophila/enzimologia , Éxons/genética , Feminino , Expressão Gênica/genética , Regulação da Expressão Gênica no Desenvolvimento , Regulação Enzimológica da Expressão Gênica , Íntrons/genética , Masculino , Especificidade de Órgãos , RNA Mensageiro/química , Sequências Reguladoras de Ácido Nucleico/genética , Sequências Repetitivas de Ácido Nucleico , Homologia de Sequência do Ácido Nucleico , Transcrição Gênica/genética
3.
Neuroscience ; 65(2): 463-76, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7777161

RESUMO

Immunolesions of the cholinergic basal forebrain were produced in rats using various intraventricular doses of the immunotoxin 192 immunoglobulin G-saporin: 0.34, 1.34, 2.0, 2.7 and 4.0 micrograms/rat. A battery of behavioral tests, chosen on the basis of reported sensitivity to conventional medial septal or nucleus basalis lesions, was administered. Dose-dependent impairments were found in acquisition, spatial acuity and working memory in the water maze. Dose-dependent hyperactivity in the open field and in swimming speed was observed. The highest dose group (4.0 micrograms) exhibited motoric disturbances which were particularly apparent in swimming and in clinging to an inclined screen. Response and habituation to acoustic startle were diminished in the three higher dose groups. Histological results from acetylcholinesterase and low-affinity nerve growth factor receptor staining showed that the lesion was selective for cholinergic neurons bearing p75 nerve growth factor receptors in the basal forebrain nuclei. However, some Purkinje cells in the superficial layers of the cerebellum were also destroyed at the higher doses of immunotoxin. The activity of choline acetyltransferase, used as a marker of cholinergic deafferentation in regions innervated by the basal forebrain nuclei, was decreased with increasing doses to a plateau level of about 90% (average depletion) for the two highest dose groups. These two groups were the only ones to exhibit consistent and severe behavioral impairments on all behavioral tests performed. Thus, for a relatively selective cholinergic basal forebrain lesion, almost a 90% reduction in choline acetyltransferase activity is needed to produce substantial behavioral deficits. It appears that either a considerable safety factor exists or robust compensatory mechanisms can ameliorate behavioral deficits from a major, but incomplete loss of cholinergic basal forebrain innervation.


Assuntos
Comportamento Animal/efeitos dos fármacos , Imunotoxinas/toxicidade , N-Glicosil Hidrolases , Neurônios/efeitos dos fármacos , Sistema Nervoso Parassimpático/fisiologia , Proteínas de Plantas/toxicidade , Prosencéfalo/efeitos dos fármacos , Células de Purkinje/efeitos dos fármacos , Animais , Monoaminas Biogênicas/metabolismo , Colina O-Acetiltransferase/metabolismo , Habituação Psicofisiológica/efeitos dos fármacos , Histocitoquímica , Imunoglobulina G , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Memória/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Sistema Nervoso Parassimpático/citologia , Ratos , Ratos Endogâmicos F344 , Reflexo de Sobressalto/efeitos dos fármacos , Proteínas Inativadoras de Ribossomos Tipo 1 , Saporinas , Redução de Peso/efeitos dos fármacos
4.
Neurochem Int ; 8(2): 243-7, 1986.
Artigo em Inglês | MEDLINE | ID: mdl-20493053

RESUMO

Functional denervation of the central adrenergic receptors by 30 daily injections of reserpine (0.25 mg/kg/day s.c.) produced an increase in the B(max) of alpha-l adrenergic receptor binding sites labeled by [(3)H]prazosin. A similar increase was also observed for the alpha-1 adrenergic receptor component of [(3)H]WB4101 binding in the hippocampus but not in the cortex. No change in the lower affinity [(3)H]WB4101 binding site, which identifies S-l serotonin receptors was detected after this treatment. These data support the hypothesis that alpha-1 receptors are regulated by their neurotransmitter and may explain why previous studies have not detected alpha-1 receptor increases following 6-hydroxydopamine lesions of the dorsal bundle and locus coeruleus.

5.
Brain Res ; 918(1-2): 113-20, 2001 Nov 09.
Artigo em Inglês | MEDLINE | ID: mdl-11684049

RESUMO

The degree of lesion produced by 192 IgG-saporin relative to controls was compared using three independent methods. Microdialyzed acetylcholine (ACh), choline acetyltransferase (ChAT) activity, and the rate of ACh synthesis were compared in the frontal cortex and hippocampus. Microdialysis of rats was performed 1 and 15 weeks post-lesion. In week 16, the rats were sacrificed after an injection of deuterated choline (Ch) for determination of the rate of ACh synthesis. ChAT activity was determined at the same timepoints in a separate set of rats. At 1 week, ChAT activity and microdialyzed ACh showed similar degrees of depletion. At 15 weeks, microdialyzed ACh was significantly lower than the synthesis rate in cortex, but not in hippocampus. A small increase in ChAT activity between 1 and 15 weeks was found in the cortex, but not hippocampus. In the hippocampus, however, the rate of ACh synthesis was significantly greater than ChAT activity. This was true for two doses of immunotoxin; the greater compensation occurring with the lesser lesion. Microdialyzed ACh levels were not different from the other measures in hippocampus. Residual cholinergic terminals in the hippocampus, but not frontal cortex, compensate for a selective cholinergic lesion by increasing the rate of synthesis and may thereby alleviate hippocampus-dependent behavioral deficits.


Assuntos
Acetilcolina/biossíntese , Núcleo Basal de Meynert/efeitos dos fármacos , Fibras Colinérgicas/efeitos dos fármacos , Lobo Frontal/metabolismo , Hipocampo/metabolismo , Vias Neurais/efeitos dos fármacos , Núcleos Septais/efeitos dos fármacos , Animais , Anticorpos Monoclonais/farmacologia , Núcleo Basal de Meynert/metabolismo , Núcleo Basal de Meynert/fisiopatologia , Colina O-Acetiltransferase/metabolismo , Colinérgicos/farmacologia , Fibras Colinérgicas/metabolismo , Relação Dose-Resposta a Droga , Espaço Extracelular/metabolismo , Lobo Frontal/fisiopatologia , Hipocampo/fisiopatologia , Imunotoxinas/farmacologia , Masculino , Microdiálise , N-Glicosil Hidrolases , Vias Neurais/metabolismo , Vias Neurais/fisiopatologia , Ratos , Ratos Endogâmicos F344 , Proteínas Inativadoras de Ribossomos Tipo 1 , Saporinas , Núcleos Septais/metabolismo , Núcleos Septais/fisiopatologia , Fatores de Tempo
6.
J Biol Chem ; 275(3): 1533-40, 2000 Jan 21.
Artigo em Inglês | MEDLINE | ID: mdl-10636841

RESUMO

We cloned cDNA encoding Drosophila DNA topoisomerase III. The top3 cDNA encodes an 875-amino acid protein, which is nearly 60% identical to mammalian topoisomerase IIIbeta enzymes. Similarity between the Drosophila protein and the topoisomerase IIIbetas is particularly striking in the carboxyl-terminal region, where all contain eight highly conserved CXXC motifs not found in other topoisomerase III enzymes. We therefore propose the Drosophila protein is a member of the beta-subfamily of topoisomerase III enzymes. The top3beta gene is a single-copy gene located at 5 E-F on the X chromosome. P-element insertion into the 5'-untranslated region of this gene affects topoisomerase IIIbeta protein levels, but not the overall fertility and viability of the fly. We purified topoisomerase IIIbeta to near homogeneity and observed relaxation activity only with a hypernegatively supercoiled substrate, but not with plasmid DNA directly isolated from bacterial cells. Despite this difference in substrate preference, the degree of relaxation of the hypernegatively supercoiled substrate is comparable to relaxation of plasmid DNA by other type I enzymes. Drosophila topoisomerase IIIbeta forms a covalent linkage to 5' DNA phosphoryl groups, and the DNA cleavage reaction prefers single-stranded substrate over double-stranded, suggesting an affinity of this enzyme for DNA with non-double-helical structure.


Assuntos
DNA Topoisomerases Tipo I/química , DNA Topoisomerases Tipo I/genética , DNA Super-Helicoidal/metabolismo , Drosophila/enzimologia , Sequência de Aminoácidos , Animais , Western Blotting , Clonagem Molecular , DNA Topoisomerases Tipo I/fisiologia , Isoenzimas/química , Isoenzimas/genética , Dados de Sequência Molecular , Mutagênese , Cloreto de Potássio/farmacologia , Homologia de Sequência de Aminoácidos , Cloreto de Sódio/farmacologia , Temperatura , Fatores de Tempo
7.
Exp Neurol ; 108(3): 221-8, 1990 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2351210

RESUMO

We administered tetrahydroaminoacridine (THA), a cholinesterase inhibitor, to rats with bilateral nucleus basalis magnocellularis lesions and measured their performance in a spatial learning task. The subjects, 34 male Fischer-344 rats, received bilateral excitotoxic NBM lesions; 10 other rats served as unlesioned controls. Two weeks later the animals were tested in a circular water maze for time and distance swum to find a submerged platform. We tested three different doses (5.0, 2.5, and 1.25 mg/kg) of daily subcutaneous THA against a lesioned control group receiving saline and a fifth group of untreated unlesioned controls. The saline-treated lesioned group showed a significant impairment of acquisition. The 1.25 mg/kg group performed significantly better than the lesioned controls with respect to latency. Analysis of swim speed data showed slowing in the 2.5 and 5.0 mg/kg groups. Analysis of the distance swum to find the platform, an untimed task that corrects for the difference in swim speeds, showed statistically significant improvement in all three treated groups. Additionally, spatial memory for the platform location was improved by two of the three doses of THA tested. Passive avoidance retention was not impaired by our lesion. All lesioned groups had comparable reductions of cortical choline acetyltransferase. Our data show significantly improved spatial learning with THA. These data provide an additional rationale for further clinical testing of THA and other centrally active cholinergic agents in diseases with cholinergic loss.


Assuntos
Aminoacridinas/farmacologia , Gânglios da Base/fisiologia , Memória/fisiologia , Substância Inominada/fisiologia , Tacrina/farmacologia , Acetilcolinesterase/análise , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Comportamento Animal/efeitos dos fármacos , Fibras Colinérgicas/efeitos dos fármacos , Modelos Animais de Doenças , Masculino , Atividade Motora/efeitos dos fármacos , Ratos , Ratos Endogâmicos F344 , Substância Inominada/efeitos dos fármacos , Substância Inominada/enzimologia , Tacrina/farmacocinética
8.
Exp Neurol ; 130(2): 214-29, 1994 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7532591

RESUMO

Combined lesions in the medial septum/diagonal band and nucleus basalis magnocellularis (NBM) in rats were produced using three excitotoxins, ibotenate (Ibo), quisqualate (Quis), and AMPA. Reductions in choline acetyltransferase (ChAT) activity differed in the cortical regions for the three toxins (AMPA > Quis > Ibo), but were fairly similar in the hippocampus. ChAT activities were not reduced in the globus pallidus, but AMPA reduced ChAT in the amygdala. Lesions with all three toxins produced similar decrements in hippocampal and posterior cortical serotonin levels. A small reduction in posterior cortical norepinephrine was detected for Quis and Ibo lesions. Spatial memory impairments were found for all three toxin groups compared with controls in acquisition, platform reversal, and a spatial probe in the water maze. The learning deficit was greatest with the Quis lesion and equivalent for the Ibo and AMPA lesions. There was no deficit in single trial passive avoidance retention for the Ibo and AMPA groups. The AMPA group was slower than controls on both training and retention trials to enter the dark compartment. This group also showed a tendency to hypoactivity as measured in an open-field test. Excitotoxic infusions into medial septum/diagonal band and NBM produced spatial mnemonic deficits which do not parallel reductions in overall ChAT activity and do not resemble the profile of behavioral changes previously reported for NBM lesions alone using these toxins.


Assuntos
Comportamento Animal/fisiologia , Lobo Frontal/fisiologia , Neurotoxinas/farmacologia , Prosencéfalo/fisiologia , Septo Pelúcido/fisiologia , Aminoácidos/metabolismo , Animais , Aprendizagem da Esquiva/fisiologia , Monoaminas Biogênicas/metabolismo , Colina O-Acetiltransferase/metabolismo , Lobo Frontal/efeitos dos fármacos , Ácido Ibotênico/farmacologia , Masculino , Aprendizagem em Labirinto/fisiologia , Prosencéfalo/efeitos dos fármacos , Ácido Quisquálico/farmacologia , Ratos , Ratos Endogâmicos F344 , Septo Pelúcido/efeitos dos fármacos , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiônico/farmacologia
9.
J Pharmacol Exp Ther ; 251(2): 612-9, 1989 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2810114

RESUMO

Acute peripheral administration of physostigmine inhibits cortical acetylcholinesterase (AChE) for about 1 hr in the rat and improves performance on learning and memory paradigms after excitotoxic lesions of the nucleus basalis magnocellularis (NBM) in rats. This study examined the effects of continuous systemic infusion of physostigmine using osmotic minipumps. One week of continuous physostigmine infusion in normal animals inhibited cortical AChE activity in a dose-dependent manner. Doses causing near maximal (0.06 mg/kg/hr) and ED50 (0.0075 mg/kg/hr) inhibition of cortical AChE activity were used to determine the effects of continuous physostigmine administration on spatial learning in the water maze in rats with bilateral ibotenic acid lesions of the NBM. Physostigmine had no effect on the acquisition of the maze task but prevented the retention deficit measured in untreated NBM-lesioned rats. Physostigmine treatment also improved the search strategy during the spatial probe trial compared to the untreated NBM-lesioned rats. The two doses of physostigmine examined did not produce differential responses on behavioral measures. Although NBM lesions significantly depleted cortical AChE activity, physostigmine treatment reduced the activity further in a dose-dependent manner. Whereas neither the lesion nor the low dose of physostigmine altered cortical receptor binding, the higher dose of physostigmine significantly down-regulated cortical muscarinic receptor binding by 28%. These data demonstrate that enhancement of acetylcholine neurotransmission can improve memory loss and spatial strategy associated with excitotoxic NBM lesions.


Assuntos
Gânglios da Base/fisiologia , Córtex Cerebral/efeitos dos fármacos , Aprendizagem/efeitos dos fármacos , Memória/efeitos dos fármacos , Sistema Nervoso Parassimpático/efeitos dos fármacos , Fisostigmina/administração & dosagem , Substância Inominada/fisiologia , Acetilcolinesterase/análise , Doença de Alzheimer/tratamento farmacológico , Animais , Córtex Cerebral/enzimologia , Colina O-Acetiltransferase/análise , Infusões Intravenosas , Masculino , Fisostigmina/farmacologia , Ratos , Ratos Endogâmicos F344 , Receptores Muscarínicos/efeitos dos fármacos
10.
Dev Biol ; 222(1): 27-40, 2000 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-10885744

RESUMO

DNA topoisomerase I (topo I) is an essential enzyme involved in replication, transcription, and recombination. To probe the functions of topo I during Drosophila development, we used top1-deficient flies with heat-shock-inducible top1 transgenes and were able to observe both zygotic and maternal functions of top1. A critical period for the zygotic function is in the late larval and early pupal stages. Topo I is required for larval growth and cell proliferation in imaginal disc tissues. The maternal functions consist of two aspects: oogenesis and early embryogenesis. During oogenesis, topo I is detected in the nuclei of early germ-line cells and follicle cells. The mutant ovary exhibits abnormal proliferation and defective nuclear morphology in these cells. There are extranumeral germ-line cells in individual egg chambers, while the follicle cells are underreplicated. Topo I is also stored maternally in early embryos. It localizes to the nuclei during interphase and prophase, but disperses into the cytoplasm at metaphase. Embryos from the mutant mother frequently show disrupted nuclear divisions with defects in chromosome condensation and segregation. The cytological and genetic analysis of the top1 mutant demonstrates that in Drosophila, topo I plays critical roles in many developmental stages active in cell proliferation.


Assuntos
DNA Topoisomerases Tipo I/metabolismo , Drosophila melanogaster/enzimologia , Regulação da Expressão Gênica no Desenvolvimento , Animais , Sequência de Bases , Primers do DNA , DNA Topoisomerases Tipo I/genética , Drosophila melanogaster/embriologia , Drosophila melanogaster/crescimento & desenvolvimento , Desenvolvimento Embrionário , Larva/crescimento & desenvolvimento , Oogênese/genética
11.
Nature ; 386(6627): 830-3, 1997 Apr 24.
Artigo em Inglês | MEDLINE | ID: mdl-9126741

RESUMO

Cocaine blocks the reuptake of dopamine, a neurotransmitter involved in the control of movement, cognition, motivation and reward. This leads to an increase in extracellular dopamine; the reinforcing effect of cocaine is associated with elevated dopamine levels in the nucleus accumbens. But addiction to cocaine involves other effects, such as craving, loss of control and compulsive drug intake; the role of the dopamine system in these effects is less well-understood. We therefore used positron emission tomography (PET) to compare the responses of cocaine addicts and normal controls to intravenous methylphenidate, a drug that, like cocaine, causes an increase in synaptic dopamine. Addicts showed reduced dopamine release in the striatum, the brain region where the nucleus accumbens is located, and also had a reduced 'high' relative to controls. In contrast, addicts showed an increased response to methylphenidate in the thalamus (a region that conveys sensory input to the cortex). This thalamic response was associated with cocaine craving and was not seen in control subjects. Thus, our findings challenge the notion that addiction involves an enhanced striatal dopamine response to cocaine and/or an enhanced induction of euphoria. Moreover, they suggest a participation of thalamic dopamine pathways in cocaine addiction, a possibility that merits further investigation.


Assuntos
Cocaína , Corpo Estriado/efeitos dos fármacos , Inibidores da Captação de Dopamina , Dopamina/metabolismo , Transtornos Relacionados ao Uso de Substâncias/metabolismo , Adulto , Comportamento Aditivo , Corpo Estriado/metabolismo , Antagonistas de Dopamina/metabolismo , Inibidores da Captação de Dopamina/farmacologia , Humanos , Masculino , Metilfenidato/farmacologia , Racloprida , Salicilamidas/metabolismo , Autoavaliação (Psicologia) , Transtornos Relacionados ao Uso de Substâncias/psicologia , Tálamo/efeitos dos fármacos , Tálamo/metabolismo , Tomografia Computadorizada de Emissão
12.
Phys Rev Lett ; 88(10): 101802, 2002 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-11909342

RESUMO

We report values of R = sigma(e(+)e(-)-->hadrons)/sigma(e(+)e(-)-->mu(+)mu(-)) for 85 center-of-mass energies between 2 and 5 GeV measured with the upgraded Beijing Spectrometer at the Beijing Electron-Positron Collider.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA